A Quality Improvement Approach to the Management of Chronic Lymphocytic Leukemia (Med-IQ CLL)

Duke University

Status: Completed

Conditions: Chronic Lymphocytic Leukemia

Treatments: Other: Education Intervention

Study type: Interventional

Funder types: Other; Industry

Identifiers

NCT02619604

Pro00063975

Details and patient eligibility

About

This project addresses the need to improve physician knowledge and clinical practice patterns related to quality of life (QoL) concerns for patients with chronic lymphocytic leukemia (CLL).

Full description

This multifaceted initiative will include evaluating patient perspectives on their QoL, evaluating provider perspectives on managing QoL, and providing education to the whole CLL care team (hematologists/oncologists, nurse practitioners, physician assistants, and nurses) on contemporary approaches for individualized, patient-centered management of CLL. Providers, including physicians, nurse practitioners, and physician assistants will participate in educational initiatives geared towards enhancing their knowledge and confidence with managing QoL concerns for patients with CLL. Pre and post surveys will be conducted with providers to evaluate change in these areas. The project aims to train this team on how to enhance communication with patients and caregivers as a means to increase patient engagement in care and QoL in this population.

Enrollment: 50 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Clinician

• Participant must be a hematologist, oncologist, nurse practitioner, or physician assistant who practices medicine in the Duke Cancer Network
• Participant treats patients with CLL
• Participant is willing to participate in the educational component of this project

Inclusion Criteria: Patient

• Patient has a diagnosis of Chronic Lymphocytic Leukemia
• Patient is over the age of 18
• Patient is being treated at a Duke Cancer Network affiliate site,
• Patient is expected to see their physician or another member of their care team at least 3 times annually.
• Signed informed consent

Exclusion Criteria: Clinician

• None

Exclusion Criteria: Patient

• Patient is Non-English speaking
• Patient diagnosed with CLL < 60 days ago

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

50 participants in 1 patient group

Clinician education

Other group

Treatment:

Other: Education Intervention